In vitro evaluation of antimicrobial features of sugammadex

Volkan Hanci1, Ahmet Vural2, Sevgi Yılmaz Hanci3

  • 1Department of Anesthesiology and Reanimation, Medical Faculty of Dokuz Eylül University, İzmir, Turkey.

Abstract

Insights

Sugammadex, a modified gamma cyclodextrin, demonstrated no antibacterial effects against common pathogens like Staphylococcus aureus and E. coli in vitro. Sterile handling is crucial to prevent contamination of sugammadex preparations.

Area of Science:

  • Microbiology
  • Pharmaceutical Sciences
  • Drug Safety

Background:

  • Intravenous drug contamination is a production risk.
  • Sugammadex is a modified gamma cyclodextrin with unstudied antibacterial properties.
  • This research addresses the gap in knowledge regarding sugammadex's antimicrobial activity.

Purpose of the Study:

  • To investigate the in vitro antimicrobial activity of sugammadex.
  • To determine if sugammadex inhibits the growth of key bacterial species.
  • To assess the risk of bacterial contamination and proliferation within sugammadex solutions.

Main Methods:

  • Broth microdilution method used to test sugammadex against bacteria.
  • Tested microorganisms: Staphylococcus aureus, Enterococcus fecalis, Escherichia coli, Pseudomonas aeruginosa.
  • Evaluated bacterial growth in sugammadex after intentional contamination and incubation.

Main Results:

  • Sugammadex exhibited no antibacterial effect against tested microorganisms at any concentration.
  • Bacterial production was observed in sugammadex solutions after 24-hour incubation when intentionally contaminated.
  • The pH of sugammadex test solutions remained within a neutral range (6.97-7.25).

Conclusions:

  • Sugammadex possesses no intrinsic antimicrobial activity against S. aureus, E. fecalis, E. coli, or P. aeruginosa.
  • Strict sterile techniques are essential during sugammadex preparation and administration.
  • Preventing reuse and adhering to storage guidelines are critical for patient safety.